Shu Wang Clinical Trial Pipeline: 8 Active Trials

Active trials by phase

Not charted: 8 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not specified
NCT06722599	Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk…	HER2-positive Breast Cancer	Recruiting	2024-12-09
NCT06722612	Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node…	HER2-positive Breast Cancer	Recruiting	2024-12-09
NCT06711055	Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative…	HER2-positive Breast Cancer	Recruiting	2024-12-02
NCT06711068	Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast…	HER2-positive Breast Cancer	Recruiting	2024-12-02
NCT06700369	De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2…	HER2-positive Breast Cancer	Recruiting	2024-11-25
NCT06700382	Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for…	Triple Negative Breast Cancer	Recruiting	2024-11-25
NCT06693024	Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer	HER2-positive Breast Cancer	Recruiting	2024-11-20
NCT06693037	Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant…	HER2-positive Breast Cancer	Recruiting	2024-11-20